Form 4: iBio Chief Legal Officer Marc Banjak Reports Stock Purchase
SEC Form 4 Filing
Marc Banjak, Chief Legal Officer of iBio, Inc., reports purchasing shares of common stock on January 10, 2025.
Summary
- On January 10, 2025, Marc Banjak, the Chief Legal Officer of iBio, Inc., purchased 9,191 shares of common stock at a price of $2.72 per share.
- This transaction was made pursuant to a Securities Purchase Agreement with iBio, Inc.
- Following the reported transaction, Banjak directly owns 11,066 shares of iBio, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The purchase of shares by an officer can be seen as a sign of confidence, but it's a relatively small transaction.
Positives
- The purchase of shares by a company officer can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings provide transparency into insider transactions and are closely watched by investors for signals about a company's prospects.
Stakeholder Impact
- The stock purchase by a company officer may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Date of stock purchase transaction. |
| 01/13/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.